Mengis Capital Management, Inc. Novartis Ag Transaction History
Mengis Capital Management, Inc.
- $456 Million
- Q2 2025
A detailed history of Mengis Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 64,483 shares of NVS stock, worth $7.69 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
64,483
Previous 80,113
19.51%
Holding current value
$7.69 Million
Previous $8.93 Million
12.62%
% of portfolio
1.71%
Previous 1.91%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,552Shares Held
142MCall Options Held
1.64MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA10.6MShares$1.27 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.24 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.08 Billion0.26% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$850 Million0.35% of portfolio
-
Morgan Stanley New York, NY7.06MShares$842 Million0.06% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $257B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...